These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1234 related items for PubMed ID: 19735755

  • 21. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS.
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [Abstract] [Full Text] [Related]

  • 22. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.
    Lin HH, Wang LY, Hu CT, Huang SC, Huang LC, Lin SS, Chiang YM, Liu TT, Chen CL.
    J Med Virol; 2003 Apr; 69(4):471-4. PubMed ID: 12601753
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.
    Jia Y, Li L, Cui F, Zhang D, Zhang G, Wang F, Gong X, Zheng H, Wu Z, Miao N, Sun X, Zhang L, Lv J, Yang F.
    Hum Vaccin Immunother; 2014 Apr; 10(10):2983-91. PubMed ID: 25483678
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
    Rein DB, Weinbaum CM.
    Vaccine; 2008 Oct 03; 26(42):5331-3. PubMed ID: 18706957
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Economic evaluation of universal newborn hepatitis B vaccination in China.
    Lu SQ, McGhee SM, Xie X, Cheng J, Fielding R.
    Vaccine; 2013 Apr 03; 31(14):1864-9. PubMed ID: 23384752
    [Abstract] [Full Text] [Related]

  • 30. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A.
    Hepatology; 1999 Feb 03; 29(2):548-52. PubMed ID: 9918934
    [Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine.
    Kuan RK, Janssen R, Heyward W, Bennett S, Nordyke R.
    Vaccine; 2013 Aug 20; 31(37):4024-32. PubMed ID: 23707166
    [Abstract] [Full Text] [Related]

  • 32. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
    Li RC, Yang JY, Gong J, Li YP, Huang ZN, Fang KX, Xu ZY, Liu CB, Zhao K, Zhuang H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May 20; 25(5):385-7. PubMed ID: 15231157
    [Abstract] [Full Text] [Related]

  • 33. Cost effectiveness of screening immigrants for hepatitis B.
    Wong WW, Woo G, Jenny Heathcote E, Krahn M.
    Liver Int; 2011 Sep 20; 31(8):1179-90. PubMed ID: 21745300
    [Abstract] [Full Text] [Related]

  • 34. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.
    Arguedas MR, Heudebert GR, Fallon MB, Stinnett AA.
    Am J Gastroenterol; 2002 Mar 20; 97(3):721-8. PubMed ID: 11922569
    [Abstract] [Full Text] [Related]

  • 35. Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program.
    Chen CC, Yen CH, Wu WY, Hu SW, Chen SC, Bell WR, Lee MC.
    Chin Med J (Engl); 2007 Jul 05; 120(13):1155-8. PubMed ID: 17637244
    [Abstract] [Full Text] [Related]

  • 36. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E, Spada E, National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group.
    Clin Infect Dis; 2008 Mar 15; 46(6):868-75. PubMed ID: 18269332
    [Abstract] [Full Text] [Related]

  • 37. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
    Krahn M, Detsky AS.
    Med Decis Making; 1993 Mar 15; 13(1):4-20. PubMed ID: 8433635
    [Abstract] [Full Text] [Related]

  • 38. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.
    J Natl Cancer Inst; 2009 Jul 15; 101(14):1019-27. PubMed ID: 19535774
    [Abstract] [Full Text] [Related]

  • 39. Cost-utility of universal hepatitis A vaccination in Canada.
    Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD.
    Vaccine; 2007 Dec 12; 25(51):8536-48. PubMed ID: 17996339
    [Abstract] [Full Text] [Related]

  • 40. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.
    Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS.
    N Engl J Med; 1997 Jun 26; 336(26):1855-9. PubMed ID: 9197213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 62.